[Chromogranin A: a marker of neuroendocrine tumors].
M. D’Herbomez, V Gouze
Abstract
M. D’Herbomez, V Gouze
Abstract
Chromogranins belong a unique family of secretory chromogranin and secretogranin proteins. They are present in the secretory vesicles throughout the neuroendocrine system. Chromogranin A is the major component. Its primary structure is well known but not yet its biological function. Chromogranin A performs as a prohormon which submits to processes of degradation. Active peptides are generated. Chromogranin A is a very used immunohistochemical marker. Reliable chromogranin A assays have been developed. In numerous studies it appear that the chromogranin A assay is reliable for the diagnosis and the follow-up of various endocrine tumors (principally the pheochromocytomas, neuroblastomas, gastrinomas and carcinoid tumors). The concentration of this general marker, in serum, reflects to the mass of the tumor. The chromogranin A levels will been interpreted in accordance to the localization of the primitive tumor, the existence of associated hormonal secretions and possible renal failure.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Chromogranins belong a unique family of secretory chromogranin and secretogranin proteins. They are present in the secretory vesicles throughout the neuroendocrine system. Chromogranin A is the major component. Its primary structure is well known but not yet its biological function. Chromogranin A performs as a prohormon which submits to processes of degradation. Active peptides are generated. Chromogranin A is a very used immunohistochemical marker. Reliable chromogranin A assays have been developed. In numerous studies it appear that the chromogranin A assay is reliable for the diagnosis and the follow-up of various endocrine tumors (principally the pheochromocytomas, neuroblastomas, gastrinomas and carcinoid tumors). The concentration of this general marker, in serum, reflects to the mass of the tumor. The chromogranin A levels will been interpreted in accordance to the localization of the primitive tumor, the existence of associated hormonal secretions and possible renal failure.
Key concepts: Chromogranin A, Neuroendocrine tumors, Immunohistochemistry, Endocrine system, Pathology, Endocrinology, Internal medicine, Biology